Subscribe to our newsletter

Inflammatory Bowel Disease Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.
STUDY VISITS
+
IBD PATIENTS
+
GASTROENTEROLOGISTS
+

Outcome measures in the CorEvitas Inflammatory Bowel Disease Registry.

Among the variables we collect, some of the key outcome measures to inform your IBD research include:

Clinician Reported Outcomes

Calculated Measures

Patient Reported Outcomes

Registry Scientific Advisors

Picture of Joshua Korzenik, MD

Joshua Korzenik, MD

Director, Crohn’s and Colitis Center, Division of Gastroenterology, Hepatology and Endoscopy, Brigham & Women’s Hospital | Assistant Professor, Harvard Medical School | CorEvitas IBD Registry Scientific Co-Director and Scientific Advisory Committee Chair

Picture of Ray Cross, MD, MS, AGAF, FACG

Ray Cross, MD, MS, AGAF, FACG

Director of the IBD Program, University of Maryland School of Medicine | Co-Director, Digestive Health Center | Professor of Medicine, Division of Gastroenterology and Hepatology, University of Maryland I CorEvitas IBD Registry Scientific Co-Director and Scientific Advisory Committee Chair

Scientific Advisory Committee

  • Jenny Sauk , UCLA
  • Doug Wolf , Atlanta Gastroenterology Associates
  • Bincy Abraham, Houston Methodist
  • Sara Horst, Vanderbilt Digestive Disease Center
  • Syan Stidham, University of Michigan
  • David Hudesman, NYU Langone Medical Center
  • Gursimran Kochhar, Allegheny General Hospital
  • Parakkal Deepak, Washington University in St. Louis